A mere 16 months following its initial funding round, a Cincinnati-based biotech startup has raised a Series A worth $15 million.
Kurome Therapeutics, a Cincinnati Children’s Hospital spinoff backed by local seed fund CincyTech, announced the eight-figure raise Thursday morning. It marks a quick ramp up for the company, which is developing novel therapies to help combat cancers like AML, or acute myeloid leukemia.
The round was co-led by Medicxi, a European-based life sciences investment firm, and Affinity Asset Advisors, a New York hedge fund focused in the biotech and health care space. CincyTech and other existing seed investors, including Queen City Angels, also participated.
Click here to read the complete story.
Story excerpt provided by Cincinnati Business Courier.
Written by Liz Engel.
Originally published June 10, 2021.